Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

3.0K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
3.0K
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

480
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
480
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

412
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
412
The Neuromuscular Junction01:19

The Neuromuscular Junction

9.6K
The nervous system consists of complex motor neuron circuits, including upper motor neurons originating from the cerebral cortex and lower motor neurons starting in the spinal cord, coordinating both voluntary and involuntary movements. Among these, somatic motor neurons activate skeletal muscles and are classified into alpha, beta, and gamma types. Alpha neurons are vital for voluntary movement coordination, while gamma neurons adjust muscle spindle sensitivity, and the function of beta...
9.6K
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

356
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
356
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

930
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
930

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NeurAnki: Behind the Scenes of Creating the First-Ever Flashcard Based Deck for Resident Education (P12-5.009).

Neurology·2026
Same author

Determination of Brain Death/Death by Neurologic Criteria in Adults: A Structured Framework for Medical Educators.

Neurology. Education·2026
Same author

Education Research: A Qualitative Analysis of the Role of Social Media in Neurology Trainees' Professional Identity Formation.

Neurology. Education·2026
Same author

Let's Talk Tech: The Role of Technology in Neurology Education.

Seminars in neurology·2026
Same author

Education Research: Entrustment and Simulated Performance of Neurocritical Care Advanced Practice Providers.

Neurology. Education·2026
Same author

The Role of Neuroimaging in Traumatic Brain and Spinal Cord Injury.

Seminars in neurology·2025
Same journal

Key Considerations in Telestroke Program Management.

Continuum (Minneapolis, Minn.)·2026
Same journal

Neurology's Action Potential: Delivering on the Promise of Brain Health.

Continuum (Minneapolis, Minn.)·2026
Same journal

Erratum.

Continuum (Minneapolis, Minn.)·2026
Same journal

Management of Large Artery Atherosclerosis.

Continuum (Minneapolis, Minn.)·2026
Same journal

Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke.

Continuum (Minneapolis, Minn.)·2026
Same journal

Stroke in Children and Younger Adults.

Continuum (Minneapolis, Minn.)·2026
See all related articles

Related Experiment Video

Updated: Jun 24, 2025

Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models
04:30

Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models

Published on: March 8, 2024

696

Neuromuscular Emergencies.

Catherine S W Albin

    Continuum (Minneapolis, Minn.)
    |June 3, 2024
    PubMed
    Summary
    This summary is machine-generated.

    This guide covers diagnosing and treating abrupt neuromuscular weakness, focusing on inflammatory causes and new therapies. Prompt respiratory support and targeted immunosuppression are key for effective patient management.

    More Related Videos

    Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients
    09:44

    Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients

    Published on: April 12, 2011

    81.1K
    The Muscle Cuff Regenerative Peripheral Nerve Interface for the Amplification of Intact Peripheral Nerve Signals
    07:30

    The Muscle Cuff Regenerative Peripheral Nerve Interface for the Amplification of Intact Peripheral Nerve Signals

    Published on: January 13, 2022

    2.0K

    Related Experiment Videos

    Last Updated: Jun 24, 2025

    Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models
    04:30

    Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models

    Published on: March 8, 2024

    696
    Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients
    09:44

    Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients

    Published on: April 12, 2011

    81.1K
    The Muscle Cuff Regenerative Peripheral Nerve Interface for the Amplification of Intact Peripheral Nerve Signals
    07:30

    The Muscle Cuff Regenerative Peripheral Nerve Interface for the Amplification of Intact Peripheral Nerve Signals

    Published on: January 13, 2022

    2.0K

    Area of Science:

    • Neurology
    • Immunology
    • Critical Care Medicine

    Background:

    • Neuromuscular weakness often stems from inflammatory processes, with increasing identification of pathogenic antibodies.
    • Neuromuscular junction disorders and myopathies are recognized adverse effects of novel anticancer therapies like immune checkpoint inhibitors.
    • Guillain-Barré syndrome and other neuromuscular emergencies are increasingly studied for neuroprognostication.

    Purpose of the Study:

    • To outline the clinical approach for patients with abrupt or acutely worsening neuromuscular weakness.
    • To detail diagnostic considerations and treatment strategies for these emergent conditions.
    • To familiarize readers with the latest advancements in understanding and managing neuromuscular disorders.

    Main Methods:

    • Clinical review of diagnostic and treatment strategies for neuromuscular emergencies.
    • Emphasis on prompt respiratory assessment and supportive care.
    • Neurologic localization and consideration of immune-mediated pathways.

    Main Results:

    • Accurate diagnosis is enhanced by recognizing pathologic antibodies causing neuromuscular injury.
    • Immune checkpoint inhibitors are linked to specific neuromuscular junction disorders and myopathies.
    • Frameworks for neuroprognostication are evolving with new data.

    Conclusions:

    • Prompt respiratory support is critical in managing neuromuscular emergencies.
    • Neurologic localization guides diagnostic considerations.
    • Tailored, aggressive immunosuppression is often necessary for immune-mediated neuromuscular disorders, considering patient-specific factors.